Below is a list of forthcoming submissions that have recently been added to the SMC's work programme:

• ​Bevacizumab (Avastin)
• Budesonide (Cortiment)
• Degludec liraglutide (Xultophy)
• Empagliflozin with metformin hydrochloride (Synjardy)
• Fluticasone proprionate with eformoterol fumarate dihydrate (Flutiform)
• Midodrine hydrochloride (Bramox)
• Pembrolizumab (Keytruda)
• Travoprost (Travatan)

For more details, go to: http://www.scottishmedicines.org.uk/SMC_Advice/Forthcoming_Submissions/Forthcoming_Submissions?iru=2ICSSBDQBC